App-Quantinova.ai

Observational study of outcomes in patients with antiphospholipid syndrome anticoagulated with Rivaroxaban

T. W. Htut - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

rivaroxaban

Thromboembolism in adult patients with acute lymphoblastic leukaemia / lymphoma: past and future practice in a tertiary centre

A. Bond - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Asparaginase

A case series of anticoagulation in mechanical and valvular heart disease in pregnancy

K. White - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Enoxaparin

Anticoagulation in palliative and end of life care ‐ results of a supra‐regional audit and literature review

K. Moss - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

The CAVEaT multicentre audit of venous thrombosis in patients with haematolical malignancy and thrombocytopenia: preliminary results.

S. Booth - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Incidence and management of PEGylated‐asparaginase related thrombosis in adults with ALL

M. Poynton - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Asparaginase

A little learning is a dangerous thing – how little do we know about when to treat pulmonary embolism?

M. Maybury - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fondaparinux sodium

An audit of complications arising in central venous access devices (CVADs) in adult haematology patients, Chesterfield Royal Hospital

R. Faulkner - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

vancomycin capsule

A case of refractory heparin‐induced thrombocytopenia

N. Ramachandran - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Real‐world experience of KPD use in relapsed or refractory myeloma

A. Barrett - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Dexamethasone

Single centre retrospective cohort study of the occurrence of venous thromboembolism in patients receiving immunomodulator‐based therapy for the treatment of multiple myeloma

S. A. Bassiony - British Society for Hematology (BSH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Angiology

Venous thrombosis

Dexamethasone

Inhibition of C3 with APL‐2 Results in Normalisation of Markers of Intravascular and Extravascular Haemolysis in Patients with Paroxysmal Nocturnal Haemoglobinuria

R. Wong - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Eculizumab

A HaemSTAR‐led, UK‐wide “Flash‐Mob” audit of intravenous immunoglobulin use in immune thrombocytopenia

P.L. Nicolson - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

IVIG

A quality improvement project to increase risk assessment for Venous Thromboembolism (VTE) to meet a national target in a large teaching hospital

H. Rowswell - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Parasite histones are associated with poor outcome in cerebral malaria

C. Moxon - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Antithrombin III Replacement in patients with Acute Lymphoblastic Leukaemia undergoing L‐asparaginase based chemotherapy regimens

L. Attwell - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Asparaginase

Evaluation of the introduction of Physician Associates in the Haematology Department at Guy's and St. Thomas’ Hospitals Foundation NHS Trust

D. Sealy - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK‐MPN‐MF registry)

N.M. Butt - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Mutational profiling in triple‐negative essential thrombocythaemia with targeted next‐generation sequencing

O. Michail - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

EZH2

Thromboprophylaxis walk around leads to increased compliance in completing thromboprophylaxis risk assessments and a decrease in Preventable Hospital Acquired Thrombosis

C. Welburn - British Society for Hematology (BSH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts